Investigation Overview
March 11, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) was announced over potential breaches of fiduciary duties by certain officers and directors at Cyclacel Pharmaceuticals. The investigation by a law firm concerns whether certain Cyclacel Pharmaceuticals directors breached their f...
You must register (for free) or login to view the entire investigation.